DISCOUNT-ZERTIFIKAT - MODERNA Stock

Certificat

DE000SV9PB20

Market Closed - Deutsche Boerse AG 15:51:01 2024-05-17 EDT
88.83 EUR +0.18% Intraday chart for DISCOUNT-ZERTIFIKAT - MODERNA
Current month+4.26%
1 month+7.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 88.83 +0.18%
24-05-16 88.67 +0.77%
24-05-15 87.99 -0.32%
24-05-14 88.27 -0.03%
24-05-13 88.3 +1.28%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 03:51 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying MODERNA, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SV9PB2
ISINDE000SV9PB20
Date issued 2023-07-13
Maturity 2024-09-20 (125 Days)
Parity 1 : 1
Emission price 75.5
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 88.9
Lowest since issue 55.72
Spread 0.02
Spread %0.02%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
132.9 USD
Average target price
138.5 USD
Spread / Average Target
+4.22%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW